Tampa, FLNCT06662942Now EnrollingIRB Ready

Vulvar Lichen Sclerosus Clinical Trial in Tampa, FL

Access cutting-edge vulvar lichen sclerosus treatment through this phase 1 clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.

Sponsored by Andrew T. Goldstein, MD

Quick Self-Assessment

See if you qualify for this Tampa location

Preparing your pre-screening questions…

Expert Care in Tampa

Access vulvar lichen sclerosus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related vulvar lichen sclerosus treatment provided free

Apply for This Tampa Location

Check if you qualify for this vulvar lichen sclerosus clinical trial in Tampa, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tampa

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tampa site if eligible
  4. 4Begin participation

About This Vulvar Lichen Sclerosus Study in Tampa

This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.

Sponsor: Andrew T. Goldstein, MD

Who Can Participate

Inclusion Criteria

Female, 18 years or older.
With a diagnosis of biopsy proven vulvar lichen sclerosus.
Signed written informed consent.
Willingness and ability to comply with the study requirements.
Subject must have a score of 10 or greater in the VQLI at screening.
Must be on a stable regimen of topical corticosteroids or topical calcineurin inhibitor for at least 2 months prior to the screening visit.
Women currently on a stable regimen of intravaginal estrogen therapy for at least 2 months may remain on the estrogen therapy throughout the study.
Women currently using topical estrogen therapy on the vulva must stop two weeks prior to enrolling in the study.
Women must have a culture negative for candidiasis or bacterial vaginosis at screening.

Exclusion Criteria

Who are immunocompromised (e.g., lymphoma, AIDS, Wiskott-Aldrich Syndrome) or have an uncontrolled malignant disease.
Who suffer from a topical or systemic infections (bacterial, viral or fungal) at the time of screening. Subjects who screen positive for either candidiasis or bacterial vaginosis at the screening visit may be treated and retested and may participate if the confirmatory test after treatment is negative. Any vulvovaginal infections during their participation in the study will be considered an adverse event. The subject will then stop the study IP and will be treated for the infection and may resume use of the IP 3 days after the last dose of medication for the infection. They will be discontinued from the study if they have two infections during the study.
Who have been diagnosed with lichen planus, psoriasis, intraepithelial neoplasia, or carcinoma of the vulva.
Who had received an investigational drug within four weeks prior to the study or who intend to use other investigational drugs during the course of this study.
Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study.
Who have a history of substance abuse or any factor, which limits the subject's ability to cooperate with the study procedures.
Who are uncooperative, known to miss appointments (according to subjects' records) and are unlikely to follow medical instructions or are not willing to attend regularly scheduled visits.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tampa?

Yes, this clinical trial (NCT06662942) has an active research site in Tampa, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Vulvar Lichen Sclerosus Treatment Options in Tampa, FL

If you're searching for vulvar lichen sclerosus treatment options in Tampa, FL, this clinical trial (NCT06662942) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tampa research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced vulvar lichen sclerosus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all vulvar lichen sclerosus clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Tampa, FL

See all interstitial cystitis clinical trials recruiting in Tampa — not just this study.

Browse Interstitial Cystitis Trials in Tampa →

Browse More Trials by Condition

Interstitial Cystitis TrialsLichen Sclerosus TrialsAll Conditions →

Ready to Join in Tampa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tampa, FL